Immediate Impact

1 by Nobel laureates 4 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
2025 Standout
1 intermediate paper

Works of Timothy Riiff being referenced

Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans
2018
A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes
2008

Author Peers

Author Last Decade Papers Cites
Timothy Riiff 94 83 47 96 8 276
Abraham Dalu 40 19 9 33 10 306
Sheng Yan 136 43 11 21 11 328
Mats Rudling 104 34 12 76 6 326
Yu Jung Heo 85 109 8 76 12 316
Marcin Kleibert 80 35 20 45 14 277
Yilie Liao 69 59 6 44 14 200
Vanessa M. Silva 30 38 6 33 10 275
Mohini Aras 94 30 15 74 7 265
Xiaogang Liu 103 30 12 33 14 291
Chu‐Yen Chien 152 42 7 26 12 306

All Works

Loading papers...

Rankless by CCL
2026